ANIP
ANI PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$72.56
+0.37%Forward multiples
Based on analyst estimates
- P/E forward
- 7.51x
- P/E 2026E
- 7.81x
- P/E 2027E
- 7.12x
- P/E 2028E
- 6.22x
- P/S forward
- 1.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.02x
- PEG TTM
- 0.15x
- Price / book
- 2.79x
- Price / sales
- 1.70x
- Price / cash flow
- 8.79x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 1.66x
- EV / EBITDA
- 6.33x
- EV / EBIT
- 10.79x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026